Completing a treatment program feels, understandably, like crossing a finish line. There is a discharge date, sometimes a small ceremony, congratulations from staff and peers, and then a drive home. But in clinical terms, finishing a primary treatment program is closer to a graduation from one phase of care than an ending. What happens in the weeks and months immediately after matters just as much, and in some ways more, than the program itself.
The American Society of Addiction Medicine (ASAM) organizes addiction treatment into a continuum of levels of care, and the popular image of rehab, a 28 or 30-day residential stay, represents just one point on that continuum. Discharge from residential treatment is designed to be a step down to a less intensive level of care, not a step off the continuum entirely. Skipping that step down, going straight from residential treatment back to full independence with no structured follow-up, is one of the most common and most preventable reasons early recovery becomes fragile.
This is the part most people are never told clearly, and it deserves to be said plainly rather than softened. Research associated with the National Institute on Drug Abuse (NIDA), building on landmark work by addiction researcher A. Thomas McLellan and colleagues published in JAMA, has found that roughly 40 to 60 percent of people treated for substance use disorder experience a return to use within the first year after treatment. Multiple longitudinal studies also show that relapse events concentrate heavily in the first 30 to 90 days after discharge, which is precisely the window when structured aftercare support is often thinnest.
NIDA's own framing of this statistic is important context: these relapse rates are comparable to, and in some cases lower than, relapse rates for other chronic medical conditions people manage over a lifetime, including hypertension, type 1 diabetes, and asthma. Nobody frames a blood pressure spike as a moral failure or a sign that treatment for hypertension does not work. The same logic applies here. A return to use after treatment is not evidence that treatment failed. It is evidence, consistent with how chronic conditions generally behave, that ongoing management after the acute treatment phase matters enormously.
The encouraging half of this picture matters too. Research aligned with NIDA's chronic disease model indicates that relapse risk drops substantially the longer someone sustains recovery, falling to a small fraction of the first-year rate after several years of continuous recovery. Time in recovery, combined with continued support, meaningfully changes the odds.
"Aftercare" is not one single thing. It is a menu of step-down options that a treatment team typically starts planning before discharge day even arrives, not as an afterthought. A well-run treatment program will usually begin this planning process a week or more before discharge, involving the patient directly in choosing which combination of options fits their life circumstances, rather than handing over a generic printed list on the last day.
| Continuing Care Option | What It Provides |
|---|
| Intensive outpatient program (IOP) | Multiple structured sessions per week, combining group therapy, individual counseling, and psychoeducation, while living at home or in sober housing |
| Partial hospitalization program (PHP) | A more intensive day-program structure than IOP, often used as a direct step down from residential treatment |
| Sober living or transitional housing | Structured, substance-free housing with accountability measures, often paired with outpatient treatment |
| Continued individual therapy | Regular one-on-one sessions addressing underlying trauma, co-occurring mental health conditions, or relapse triggers identified during treatment |
| Medication continuation | Ongoing use of medications such as buprenorphine, naltrexone, or methadone for those on medication-assisted treatment, which research shows meaningfully reduces relapse risk for opioid use disorder specifically |
| Mutual-help groups | Peer-based groups such as 12-step programs or non-12-step alternatives, providing ongoing community and accountability at low or no cost |
| Recovery coaching or case management | Non-clinical support focused on practical reintegration, employment, housing stability, and connecting to ongoing resources |
Most people in stable, sustained recovery are not using just one of these. They are typically combining two or three, for example, an IOP schedule alongside sober living and a weekly mutual-help meeting, layered together for the first several months after discharge.
Consider someone who completes 30 days of residential treatment for alcohol use disorder. If they return directly home with no follow-up plan, they are stepping from a highly structured, substance-free environment back into the same house, same routines, and often the same triggers that were present before treatment, with none of the daily clinical support that made the residential stay effective. Now consider the same person stepping down into an IOP schedule three evenings a week, moving into a sober living home for the first 90 days, and attending a weekly mutual-help meeting. The clinical environment has not disappeared overnight; it has gradually decreased in intensity while the person rebuilds daily life skills with a safety net still in place. This is precisely the mechanism continuing care research points to: gradual reduction of support, not an abrupt cliff.
The concentration of relapse events in the early post-discharge window is not simply about willpower running out. During active treatment, particularly residential care, the environment is deliberately engineered to remove triggers, structure time, and provide constant access to support. Discharge reintroduces all of that complexity at once: unstructured time, the original social environment, financial and relationship stressors that treatment paused rather than resolved, and often the very triggers that were present before treatment began. A dynamic model of relapse developed by researchers Witkiewitz and Marlatt describes this as an interaction between longer-term vulnerability factors, such as family history and social support, and the specific coping response available in the moment a high-risk situation appears. Continuing care exists specifically to keep that coping response accessible and rehearsed during the exact window when it is needed most, rather than leaving someone to rebuild those skills alone under real-world pressure for the first time.
Beyond clinical care, the months after treatment usually involve practical reentry challenges that are rarely discussed in treatment marketing: returning to work or explaining a gap in employment, rebuilding trust with family members, navigating social situations where substances are present, and simply relearning how to structure unstructured time, which was often filled by substance use before treatment began. Employees returning from treatment have specific legal protections worth understanding; our guide to legal rights and time off for rehab covers this in detail.
Addiction researchers increasingly use the term recovery capital to describe the cumulative resources, personal, social, and community, that support sustained recovery: stable housing, employment, healthy relationships, a sense of purpose, and a supportive peer network. Continuing care is not just about preventing relapse in a narrow, reactive sense. It is about actively building this broader foundation during the window when someone has the most clinical support available to do so.
Addiction researchers increasingly use the term recovery capital to describe the cumulative resources, personal, social, and community, that support sustained recovery: stable housing, employment, healthy relationships, a sense of purpose, and a supportive peer network. Continuing care is not just about preventing relapse in a narrow, reactive sense. It is about actively building this broader foundation during the window when someone has the most clinical support available to do so.
This is also where medication plays a role many people do not expect after leaving a residential program. For opioid use disorder specifically, continuing medications such as buprenorphine or methadone after discharge is associated with substantially lower relapse rates compared to abstinence-only approaches, according to research summarized by both SAMHSA and NIDA. Some studies of abstinence-only pathways for opioid use disorder found first-year relapse rates as high as 60 to 90 percent, a range that drops considerably when medication is continued as part of the aftercare plan rather than discontinued at discharge. This is one of the clearest examples of why the plan for the weeks after treatment matters just as much as the treatment itself.
- Understand that a return to use, if it happens, is a signal to adjust the level of care, not a reason to withdraw support
- Support engagement with a relapse prevention plan built before discharge, rather than assuming willpower alone will carry the person through
- Recognize the first 90 days as a genuinely higher-risk window clinically, and plan extra support and check-ins accordingly rather than easing off once the residential stay ends
- Continue any family therapy or education component the treatment program offered, since family involvement is consistently associated with better outcomes across the continuing care research
If you are building out a specific plan for this phase, our guide to creating a relapse prevention plan and our explainer on how sober living homes work are useful next steps, and our overview of what happens in the first 30 days of rehab is worth revisiting to see how the beginning and end of a treatment episode are designed to connect.
Frequently asked questions
No. Completing a primary treatment program is a step down to a less intensive level of care, not an endpoint. Structured continuing care after discharge is strongly associated with better long-term outcomes.
Research associated with NIDA and landmark studies by A. Thomas McLellan found that roughly 40 to 60 percent of people treated for substance use disorder experience a return to use within the first year, a rate comparable to other chronic conditions like hypertension and diabetes.
Multiple longitudinal studies show relapse events concentrate heavily in the first 30 to 90 days after discharge, which is why structured step-down care during this specific window matters most.
Common options include intensive outpatient programs, partial hospitalization programs, sober living housing, continued individual therapy, medication continuation for those on MAT, mutual-help groups, and recovery coaching.
Not according to how addiction researchers understand chronic conditions. A return to use is generally treated as a signal to adjust the level of care and support, similar to how a blood pressure spike signals a need to adjust hypertension management, not evidence that treatment itself failed.
Recovery capital refers to the cumulative personal, social, and community resources, such as stable housing, employment, healthy relationships, and peer support, that researchers have found support sustained long-term recovery.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
